Advertisement

Topics

Canadian Genetic Disease Network Company Profile

16:38 EDT 25th September 2017 | BioPortfolio

To be the primary catalyst in advancing Canada's scientific and commercial competitiveness in genetic research and the application of genetic discoveries to the prevention, diagnosis and treatment of human disease.

Location

Suite 201, 2150 Western Parkway
Vancouver
British Columbia
V6T 1V6
United Kingdom

Contact

Phone: (604) 221-7300
Fax: (604) 221-0778
Email: lmauro@cgdn.ca


News Articles [4208 Associated News Articles listed on BioPortfolio]

Network propagation: a universal amplifier of genetic associations

Network propagation is based on the principle that genes underlying similar phenotypes are more likely to interact with each other. It is proving to be a powerful approach for extracting biological in...

Genetic modifier for Huntington's disease progression identified

A team led by UCL and Cardiff University researchers has developed a novel measure of disease progression for Huntington's disease, which enabled them to identify a genetic modifier associated with ho...

Classification of common human diseases derived from shared genetic and environmental determinants

Andrey Rzhetsky and colleagues analyze electronic medical records from over one-third of the US population to estimate disease heritability and to determine the genetic and environmental contributions...

A new genetic marker for schizophrenia

Schizophrenia is a complicated disease that often appears in early adulthood. Although scientists have not traced the genetic causes, more than 80% of schizophrenia cases are considered to have a here...

Researchers perform first-ever clinical trial involving genetic screening for Parkinson’s disease

In the first ever clinical investigation involving genetic screening for Parkinson's disease, researchers are testing whether the presence of a specific genetic mutation identifies which patients are ...

Settling the score: variant prioritization and Mendelian disease

For clinical cases of Mendelian disease that lack a genetic diagnosis, genome and exome sequencing are increasingly used for seeking the genetic cause. This Review discusses the strategies and computa...

Large genomic databases hold clues linking genetic mutations to future disease risk

Physicians are increasingly using genetic testing to unravel mysterious or rare diseases in patients with baffling symptoms. But untangling mystifying symptoms is only half the battle. The next fronti...

Human genetic variation and the gut microbiome in disease

Recent microbiome genome-wide association studies have identified numerous associations between human genetic variants and the gut microbiome. Here, the authors review how genetic variation in the hos...

Drugs and Medications [6 Associated Drugs and Medications listed on BioPortfolio]

Colgate [Colgate-Palmolive Canada]

Colgate Fluoride Toothpaste

Healthcare [Canadian Custom Packaging Company]

HealthCare Plus Alcohol Swab

Strivectin-sh nia-114 uva uvb shields spf 30 [StriVectin Operating Company Inc.]

StriVectin-SH NIA-114 + UVA/UVB Shields SPF 30

Terbinex [Innocutis]

Terbinex (terbinafine Hydrochloride tablets equivalent to 250mg base)

Fluress [Akorn, Inc.]

FLURESS

PubMed Articles [9793 Associated PubMed Articles listed on BioPortfolio]

Letter to the Editor -- Who benefits from the professionalization of health promotion?

In 2007, Health Promotion Ontario (HPO) began working to advance the "profession" of health promotion (HP) in Canada through development of national competencies for health promoters. Their work was c...

Genetic analysis of the Candida albicans biofilm transcription factor network using simple and complex haploinsufficiency.

Biofilm formation by Candida albicans is a key aspect of its pathobiology and is regulated by an integrated network of transcription factors (Bcr1, Brg1, Efg1, Ndt80, Rob1, and Tec1). To understand th...

Germline Genetic Variants with Implications for Disease Risk and Therapeutic Outcomes.

Genetic testing has multiple clinical applications including disease risk assessment, diagnosis and pharmacogenomics. Pharmacogenomics can be utilized to predict whether a pharmacologic therapy will b...

Women's Heart Health: Knowledge, Beliefs, and Practices of Canadian Physicians.

Heart disease is a leading cause of morbidity and mortality in women. To date, the majority of knowledge regarding heart disease is based on research conducted in men. As a result, a male-oriented mod...

Expected Number of Fixed Points in Boolean Networks with Arbitrary Topology.

Boolean network models describe genetic, neural, and social dynamics in complex networks, where the dynamics depend generally on network topology. Fixed points in a genetic regulatory network are typi...

Clinical Trials [4852 Associated Clinical Trials listed on BioPortfolio]

Family Blood Pressure Program - GENOA (Genetic Epidemiology Network of Atherosclerosis)

GENOA, the Genetic Epidemiology Network of Arteriopathy, consists of a network of three field centers and biochemical and genetic core labs to study the common polymorphic genetic variatio...

Development of a Nation Program for Research in Severe Asthma: The Canadian Severe Asthma Network (CSAN)

The Canadian Severe Asthma Network (CSAN) was developed to gain a better understanding of the clinical, environmental, socio-economic, work-related, and biological characteristics of sever...

Hirschsprung Disease Genetic Study

Hirschsprung disease is a genetic condition caused by lack of nerve cells in varying lengths of the intestines. This study will investigate the complex genetic basis of the disease, which ...

Brain Network Activation and Gait and Posture in FXTAS

In this study we aim to identify and characterize a potential neurophysiological biomarker by mapping functional networks of brain activity (Brain Network Activation, BNA) based on analysi...

Canadian WATCHMAN Registry

Canadian WATCHMAN Registry is a multicentre (8 Centres) Canadian prospective, non-randomized, registry to enrol 100 consecutive patients undergoing LAA closure with the WATCHAN device to s...

Companies [1810 Associated Companies listed on BioPortfolio]

Bioinformatics

Bioinformatics.ca is the portal to bioinformatics activities in Canada and the home for the Canadian Genetic Disease Network (CGDN)- sponsored Canadian Bioinformatics Workshops series hosted nation-wi...

Canadian Genetic Disease Network

To be the primary catalyst in advancing Canada's scientific and commercial competitiveness in genetic research and the application of genetic discoveries to the prevention, diagnosis and treatment of ...

Genetic Analysis

Genetic Analysis has developed and launched the first gene-based routine test for the mapping and diagnosis of diseases related to dysbiosis and imbalances in the bacteria in the ...

Children's Rare Disease Network

The Children's Rare Disease Network (CDRN) is a non-profit advocacy group committed to connecting, educating and empowering the rare disease community, providing a link between families impacted by ra...

Natera, Inc.

Natera is a genetic testing company that has developed a proprietary bioinformatics technology (Parental Support) to deliver accurate and comprehensive high throughput testing for...

More Information about "Canadian Genetic Disease Network" on BioPortfolio

We have published hundreds of Canadian Genetic Disease Network news stories on BioPortfolio along with dozens of Canadian Genetic Disease Network Clinical Trials and PubMed Articles about Canadian Genetic Disease Network for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Canadian Genetic Disease Network Companies in our database. You can also find out about relevant Canadian Genetic Disease Network Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record